Contrast-enhanced vs T2-weighted MRI for mesorectal nodal staging in rectal cancer.

Lurz M, Schäfer AO

Open source

DOI
10.1007/s00330-026-12516-5
Published
2026 Aug
Container
European radiology
Publisher
Not recorded
Open access
no

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1007/s00330-026-12516-5,
  title = {Contrast-enhanced vs T2-weighted MRI for mesorectal nodal staging in rectal cancer.},
  author = {Lurz M and Schäfer AO},
  year = {2026},
  journal = {European radiology},
  doi = {10.1007/s00330-026-12516-5},
  url = {https://doi.org/10.1007/s00330-026-12516-5}
}

RIS

TY  - JOUR
TI  - Contrast-enhanced vs T2-weighted MRI for mesorectal nodal staging in rectal cancer.
AU  - Lurz M
AU  - Schäfer AO
PY  - 2026
JO  - European radiology
DO  - 10.1007/s00330-026-12516-5
UR  - https://doi.org/10.1007/s00330-026-12516-5
ER  - 

APA

M, L., & AO, S. (2026). Contrast-enhanced vs T2-weighted MRI for mesorectal nodal staging in rectal cancer.. European radiology. https://doi.org/10.1007/s00330-026-12516-5

Source records